The changing epidemiology of vancomycin-resistant Enterococcus (VRE) bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients.
about
Microbiome mediation of infections in the cancer settingBacterial Infections in Hematopoietic Stem Cell Transplant RecipientsThe intestinal microbiota and susceptibility to infection in immunocompromised patientsDevelopment of Novel Oral Formulations Prepared via Hot Melt Extrusion for Targeted Delivery of Photosensitizer to the ColonVancomycin resistance has no influence on outcomes of enterococcal bacteriuriaImpact of peri-transplant vancomycin and fluoroquinolone administration on rates of bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients: a 12-year single institution study.Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantationEuropean guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in LeukemiaRecent changes in bacteremia in patients with cancer: a systematic review of epidemiology and antibiotic resistance.Efficacy of the new lantibiotic NAI-107 in experimental infections induced by multidrug-resistant Gram-positive pathogens.Which Multidrug-Resitant Bacteria are Emerging in Patients with Hematological Malignancies?: One-Year Report.Impact of vancomycin resistance on mortality in neutropenic patients with enterococcal bloodstream infection: a retrospective study.The emergence of vancomycin-resistant enterococcal bacteremia in hematopoietic stem cell transplant recipientsRole of the commensal microbiota in normal and pathogenic host immune responsesDifferential Effects of Penicillin Binding Protein Deletion on the Susceptibility of Enterococcus faecium to Cationic Peptide AntibioticsPerformance characteristics of the Cepheid Xpert vanA assay for rapid identification of patients at high risk for carriage of vancomycin-resistant Enterococci.Enterococcal bacteremia is associated with increased risk of mortality in recipients of allogeneic hematopoietic stem cell transplantationUse of Shotgun Metagenome Sequencing To Detect Fecal Colonization with Multidrug-Resistant Bacteria in Children.Systematic review and meta-analysis of linezolid and daptomycin for treatment of vancomycin-resistant enterococcal bloodstream infections.Laboratory Diagnosis of Infections in Cancer Patients: Challenges and Opportunities.Targeted therapy against multi-resistant bacteria in leukemic and hematopoietic stem cell transplant recipients: guidelines of the 4th European Conference on Infections in Leukemia (ECIL-4, 2011).Chlorhexidine bathing for the prevention of colonization and infection with multidrug-resistant microorganisms in a hematopoietic stem cell transplantation unit over a 9-year period: Impact on chlorhexidine susceptibility.Colonization Rate and Risk Factors of Vancomycin-Resistant Enterococci among Patients Received Hematopoietic Stem Cell Transplantation in Shiraz, Southern Iran.The prevention and management of infections due to multidrug resistant organisms in haematology patientsAntibiotic resistance in cancer patients.Ceftaroline restores daptomycin activity against daptomycin-nonsusceptible vancomycin-resistant Enterococcus faecium.The challenge of antibiotic resistance in haematology patients.Multidrug-resistant Enterobacteriaceae, Pseudomonas aeruginosa, and vancomycin-resistant enterococci: Three major threats to hematopoietic stem cell transplant recipients.Colonization With Vancomycin-Resistant Enterococci and Risk for Bloodstream Infection Among Patients With Malignancy: A Systematic Review and Meta-AnalysisMultidrug-resistant bacteria in hematology patients: emerging threats.Gut microbiota and hematopoietic stem cell transplantation: where do we stand?Bacterial bloodstream infections in the allogeneic hematopoietic cell transplant patient: new considerations for a persistent nemesis.Vancomycin-resistant Enterococcus colonization and bloodstream infection: prevalence, risk factors, and the impact on early outcomes after allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia.Emerging Infections and Pertinent Infections Related to Travel for Patients with Primary Immunodeficiencies.Infection Prevention in Transplantation.The intestinal microbiota: Antibiotics, colonization resistance, and enteric pathogens.Epidemiology of bloodstream infections after myeloablative and non-myeloablative allogeneic hematopoietic stem cell transplantation: A single-center cohort study.Prediction of Bloodstream Infection Due to Vancomycin-Resistant Enterococcus in Patients Undergoing Leukemia Induction or Hematopoietic Stem-Cell Transplantation.Intestinal colonisation and blood stream infections due to vancomycin-resistant enterococci (VRE) and extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBLE) in patients with haematological and oncological malignancies.Multidrug-resistant organisms in allogeneic hematopoietic cell transplantation.
P2860
Q26752672-A3450D47-37E9-48AA-9833-FBA4F56C947DQ26799576-4B310A70-7A2D-4032-89CA-EDEB76532DF2Q26862848-8FD375E9-AF5F-4FE2-B66F-CD436B7FEB45Q29305365-C086968B-1551-4A0F-89E0-1076A550879CQ33942482-C9F6E703-9945-455E-8D22-B5695D009032Q34175284-41CDBFD9-8F36-4F3D-90AE-6CE1E6E9D6C3Q34311369-97D24749-0832-4530-BA2B-CC72A36D7D7BQ34390823-6F688C70-D245-4E63-90A9-9120FFB0A8BDQ34564797-ACA1CCED-B998-4584-8E90-E31270695DB1Q34737510-21AAC740-EFEB-4E76-9E47-1597E021CC9BQ34766770-C2A9ECE3-6F7F-4D50-BE33-E7CAF282AD05Q35027260-D9408288-AF57-4026-9680-E63E5DE7E4C2Q35047852-81AC658F-D7BC-448F-8FE0-CC5995F35806Q35448732-949928D6-B76F-4A8B-B125-0339108CD62DQ36075839-6ED4B6ED-115B-4D79-A94D-D5D53814333DQ36363123-0CB20104-2A5C-42D3-A0A7-783492927DA4Q36853960-51EB695E-E150-4449-B1B5-5DB665A205B9Q37040577-1D54A5F2-7E23-4295-8C9E-57290DF90B54Q37263709-AAADFB2B-DA1A-46AB-8B68-A0C938647202Q37363377-44F1ADCC-D730-4B74-838E-FF32C7D2CD9FQ37377897-D539A905-A3EF-4B41-90D4-5CC54FB50025Q37432941-5A34322C-2CD4-4CC3-AB80-38D79933188FQ37569162-758518B6-1B5C-417B-9E60-C1740402ACF7Q38171538-18F47EB1-BE3D-4C86-BF95-CD952CB821FEQ38212258-3F48FDE3-B86E-4A77-A878-597EEB61107DQ38325502-EE2CB89A-972F-4741-A864-A1DEF596F126Q38613929-A51D5299-FE93-4162-930F-F44D63C73F7AQ38620812-38D19CDC-4CF1-445B-8E00-284CBEEA9C80Q38799131-F761F522-A23F-4692-A123-180CAF273242Q38838498-DBFE71EC-646E-4B84-BB69-4DB5E77DA496Q38878477-8A135B70-2A76-4F4B-A526-D1631F20F2FFQ39202357-4C1679BA-5175-4CF5-A604-BD7471DEF6C1Q39375402-5CC121E9-3321-4440-AA26-1B399B586446Q40044232-D7AA9D5E-6B44-41A7-AE3A-FFD59E36C117Q40049276-5A4F96BA-8E19-4D09-960E-7919C3EFB94CQ40063718-AD50DF97-E327-4439-9717-F1DC33189392Q40179367-400C02DE-02CC-42B2-BD51-A91C7D57A407Q40267813-174ED652-DFD2-4579-9154-C6DE4BB3FC1EQ40284635-6702A74B-4E1E-4679-A2B7-D16E2106AA85Q40353479-235107EE-0F26-4C5C-9AB8-71C7845159A9
P2860
The changing epidemiology of vancomycin-resistant Enterococcus (VRE) bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
The changing epidemiology of v ...... transplant (HSCT) recipients.
@en
type
label
The changing epidemiology of v ...... transplant (HSCT) recipients.
@en
prefLabel
The changing epidemiology of v ...... transplant (HSCT) recipients.
@en
P2093
P2860
P1476
The changing epidemiology of v ...... transplant (HSCT) recipients.
@en
P2093
Ann A Jakubowski
Dick Chung
Eric G Pamer
Genovefa Papanicolaou
Kent A Sepkowitz
Mini Kamboj
Susan K Seo
P2860
P304
P356
10.1016/J.BBMT.2010.05.008
P577
2010-05-26T00:00:00Z